Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of C
about
Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to CollaborationA decision-analytic approach to define poor prognosis patients: a case study for non-seminomatous germ cell cancer patientsA 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948).Canadian consensus guidelines for the management of testicular germ cell cancer.Treatment of disseminated non-seminomatous testicular cancer: the European experience.Regular review: Managing testicular cancerCurrent status and future perspectives in the treatment of advanced testicular cancer.Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer.Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of CaCurrent management of testicular cancerGAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.Phase I study of docetaxel plus ifosfamide in patients with advanced cancer.Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours.Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosisPaternity following treatment for testicular cancer.Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy.Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).Long-term follow-up of patients with poor prognosis germ cell tumor treated with early high-dose chemotherapy with hematopoietic progenitor cell support: a single-center experience.Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?Salvage high-dose chemotherapy in patients with germ cell tumors
P2860
Q26797518-7CFBA27B-B630-4734-A390-0869D3734902Q33313043-3E0DB731-21DF-4DA5-B9FB-EAA6CB2ACDDDQ33341214-4615588E-B7B8-48D0-8DB2-AF6C16E3E8ABQ33343001-3EF7B093-104D-4E68-A49B-E601C8E95549Q33369071-726317DF-9CA3-405B-BA9C-CDE6DB75D441Q33753786-88EE916C-C960-4C9E-893D-C01D1A6CA7A5Q33788904-805CCFE5-C332-49BC-A8D0-A59AFC73B502Q33806081-C2412A2A-EBA1-40E3-B73D-474C6A5F1DCDQ34612225-63DC7660-C58D-4683-9B90-B67E847AFFEDQ35208183-075D83B7-61E1-435D-8BFF-219450BD1B55Q35456754-621C0EEC-2526-4518-AE77-867301FB2743Q35540049-7117608C-6760-4740-9266-807200E9034AQ35721076-21FE5C18-ACE0-4B82-AAFE-8BFF4A796B24Q36114922-B3C24F87-A159-48EF-9134-99401870285AQ36566495-E0C8F8E2-3BD3-4875-8C26-0DD903DCC750Q36610888-F5EC5B6F-A7ED-4ED6-B7BF-A8CDC0661305Q36646143-85463D73-94CA-4976-986E-6C1A27C4A678Q36694538-0E0DF6B8-FA0A-4372-B1F2-6C72A8782521Q37478015-1D2B4DD6-9F45-4B21-8761-29A046CF3FF3Q38275537-01FD4A83-BE97-4805-B260-DA9AA234257FQ38281052-C87F2A87-A19C-4598-9B5B-B7F9ED812F2CQ40375677-1134DB29-DCED-4980-8ABA-014506CF12F3Q42048953-1D93DC95-7BE3-4567-BB06-07BB0DC248D8Q44435533-40D612F5-B1B7-46BB-858F-79791B10643AQ53293727-4AEA7C5C-9A10-4DCC-99A5-1DC4E9C6318FQ55070614-BBCAA025-C668-451C-A926-9F27510C0F66Q57575131-0EEBE131-F1B3-498A-8CFB-2ABA66578FF3
P2860
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of C
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Intensive induction-sequential ...... or Research and Treatment of C
@en
Intensive induction-sequential ...... or Research and Treatment of C
@nl
type
label
Intensive induction-sequential ...... or Research and Treatment of C
@en
Intensive induction-sequential ...... or Research and Treatment of C
@nl
prefLabel
Intensive induction-sequential ...... or Research and Treatment of C
@en
Intensive induction-sequential ...... or Research and Treatment of C
@nl
P2093
P1476
Intensive induction-sequential ...... or Research and Treatment of C
@en
P2093
C van Groeningen
E Lallemand
L Collette
L De Prijck
P deMulder
R Sylvester
P304
P356
10.1200/JCO.1998.16.2.692
P407
P577
1998-02-01T00:00:00Z